Pharmaceutical defects: A critical review on defects of various dosage forms and regulatory impacts

K. G. Hemanth, Mahendra Joshi, Richa Dayaramani, N. Damodharan, Ravindra Shenoy, K. Girish Pai

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


In treatment of diseases, Quality and safe medicines are required which would save the human lives. Pharmaceutical Industry is one of the sectors with most stringent guidelines since it deals with human lives. Defective products from this sector is least anticipated. Defective product is the one which couldn’t fulfill the need of customer and may possess some degree of risk if it is used. If such product is released into the market, there are few consequences which manufacturing company would go through. Though Global Regulatory authorities, ICH and WHO have laid guidelines, we aren’t successful in preventing even minor defects such as discrepancies in label specification. The objective of this review article is to briefly discuss about the Pharmaceutical defects, Real-life product defects compared to textbooks recorded defects, their consequences and recent voluntary product recalls published by US-FDA which could help the Pharmaceutical Industry in enhancing their quality system.

Original languageEnglish
Pages (from-to)4505-4508
Number of pages4
JournalResearch Journal of Pharmacy and Technology
Issue number9
Publication statusPublished - 04-09-2020

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)


Dive into the research topics of 'Pharmaceutical defects: A critical review on defects of various dosage forms and regulatory impacts'. Together they form a unique fingerprint.

Cite this